We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


AnaSpec Introduces Anti- ß-Amyloid

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "AnaSpec Introduces Anti- ß-Amyloid"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AnaSpec, Eurogentec Group has announced the release of two new mouse monoclonal antibodies specific for β-Amyloid (1-40) & (1-42).

These two antibodies are of the IgG1 subtype and do not cross-react with each other at concentrations up to 50 ng/ml when tested in sandwich ELISA.

They also do not cross-react with β-amyloid (1-37) and β-amyloid (1-38). Species reactivity includes human, mouse and rat.

The immunogen used in raising anti-β-amyloid (1-40) corresponds to amino acid 35-40 (MVGGVV), and for anti-β-amyloid (1-42), aa 35-42 (MVGGVVIA).